Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Milestone

Re: yohombre

posted on Oct 11, 2009 04:54PM

Are you suggesting that this is what CURRENT directors make and are willing to work for in order to retain their seats?

There have been various suggestions regarding remuneration/fees that should be in place to show that the current BoD were actively engaged in growing PTSC.

Would your proposed candidates be prepared to accept $2,000 per year in fees, performance related bonuses based on share price(exclusive of MMP Portfolio revenues), and have a significant holding of PTSC stock(5% each would qualify), to prove their commitment to shareholders?

No, the final paragraph is a combination of what has been suggesd for the current BoD. I am a little surprised that you thought this is what I believed to be their current package.

.

.

Be well

Share
New Message
Please login to post a reply